Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2008-01-11
2010-12-28
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C435S070210, C435S007100
Reexamination Certificate
active
07858091
ABSTRACT:
Using the proteins of the present invention, DNAs encoding the proteins, and antibodies recognizing the proteins, detection methods for diseases relating to the novel insulin-like growth factor binding proteins of the present invention, as well as diagnostic agents, preventive agents, and therapeutic agents for diseases relating to the proteins of the present invention can be provided.
REFERENCES:
patent: 5597700 (1997-01-01), Konstantinov et al.
patent: 6391588 (2002-05-01), Andress et al.
patent: 2003/0148485 (2003-08-01), Taupier et al.
patent: WO 00/36105 (2000-06-01), None
patent: WO 01/83705 (2001-11-01), None
patent: WO 01/93983 (2001-12-01), None
Binkert et al., “Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2)”The EMBO Journal, 1989, pp. 2497-2502, vol. 8(9).
Burger et al., “Down Regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas”,Oncogene, 1998, pp. 2459-2467, vol. 16.
Butkus et al., “Thromboxane Production And Platelet Aggregation In Diabetic Subjects With Clinical Complications”,Thrombosis Research, 1980, pp. 211-223, vol. 19.
Clemmons, “IGF Binding Proteins and Their Functions”,Molecular Reproduction and Development, 1993, pp. 368-375, vol. 35.
Damon et al., “Developmental Regulation of Mac25/Insulin-like Growth Factor-Binding Protein-7 Expression in Skeletal Myogenesis”,Experimental Cell Research, 1997, pp. 192-195, vol. 237.
Degeorges et al., “Human Prostate Cancer Expresses the Low Affinity Insulin-like Growth Factor Binding Protein IGFBP-rP1”,Cancer Research, 1999, pp. 2787-2790, vol. 59.
Dollery et al., “Circulating Prostacyclin May Be Reduced in Diabetes”,The Lancet, 1979, p. 1365.
Halushka et al., “Increased platelet thromboxane synthesis in diabetes mellitus”,J. Lab. Clin. Med., 1981, 87-96, vol. 97(1).
Harrison et al., “Decreased Vascular Prostacyclin in Experimental Diabetes”,Life Sciences, 1978, pp. 351-356, vol. 23.
Haugk et al., “Insulin-Like Growth Factor (IGF)-Binding Protein-Related Protein-1: An Autocrine/Paracrine Factor That Inhibits Skeletal Myoblast Differentiation but Permits Proliferation in Response to IGF”,Endocrinology, 2000, pp. 100-110, vol. 141(1).
Hensby et al., “Prostacyclin Deficiency In Thrombotic Thrombocytopenic Purpura”,The Lancet, 1979, p. 748.
How et al., Insulin-Like Growth Factor Binding Proteins (IGFBPs) and IGFBP-Related Protein 1-Levels in Cerebrospinal Fluid of Children with Acute Lymphoblastic Leukemia,The Journal of Clinical Endocrinology&Metabolism, 1999, pp. 1283-1287, vol. 84(4).
Hwa et al., “Characterization of Insulin-Like Growth Factor-Binding Protein Related Protein-1 in Prostate Cells”,Journal of Clinical Endocrinology and Metabolism, 1998, pp. 4355-4361, vol. 83(12).
Hwa et al., “The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily”,Endocrine Review, 1999, pp. 761-787, vol. 20(6).
Inoguchi et al., “Abnormality in Prostacyclin-Stimulatory Activity in Sera From Diabetics”Metabolism, 1989, pp. 837-842, vol. 38(9).
Inoguchi et al., “Reduced Serum-Stimulatory Activity on Prostacyclin Production by Cultured Aortic Endothelial Cells in Diabetes mellitus”,Haemostasis, 1986, pp. 447-452, vol. 16.
Inoguchi et al., “Stimulatory activity on prostacyclin production decreases in sera from streptozotocin-induced diabetic rats”,Diabetes Research and Clinical Practice, 1987, pp. 243-248, vol. 3.
Johnson et al., “Vascular Prostacyclin May Be Reduced In Diabetes In Man”,The Lancet, 1979, pp. 325-326.
Kiefer et al., “Molecular Cloning of a New Human Insulin-Like Growth Factor Binding Protein”,Biochemical and Biophysical Research Communications, 1991, pp. 219-225, vol. 176(1).
Kiefer et al., “Identification and Molecular Cloning of Two New 30-kDa Insulin-like Growth Factor Binding Proteins Isolated from Adult Human Serum”,Journal of Biochemical Chemistry, 1991, pp. 9043-9049, vol. 266(14).
Kim et al., “Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily”, 1997, pp. 12981-12986, vol. 94.
Komatsu et al., “Methylation and Downregulated Expression of mac25/Insulin-like Growth Factor Binding Protein-7 Is Associated with Liver Tumorigenesis in SV40T/t Antigen Transgenic Mice, Screened by Restriction Landmark Genomic Scanning for Methylation (RLGS-M)”Biochemical and Biophysical Research Communications, 2000, pp. 109-117, vol. 267.
Latour et al., “Inhibitory Insulin-Like Growth Factor-Binding Protein: Cloning, Complete Sequence, and Physiological Regulation”,Molecular Endocrinology, 1990, pp. 1806-1814, vol. 4(12).
Lee, “Insulin-Like Growth Factor (IGF) Binding Protein Complementary Deoxyribonucleic Acid from Human HEP G2 Hepatoma Cells: Predicted Protein Sequence Suggests an IGF Binding Domain Different from Those of the IGF-1 and IGF-II Receptors”,Molecular Endocrinology, 1998, pp. 404-411, vol. 2(5).
MacIntyre et al., “Localisation and stimulation of prostacyclin production in vascular cells”,Nature, 1978, vol. 271.
Masakado et al., “Immunohistochemical Localization of a Novel Peptide, Prostacyclin-Stimulating Factor (PSF), in Human Tissues”,Thrombosis and Haemastasis, 1995, pp. 1407-1410, vol. 74(6).
Mehls et al., “Therapeutic Value of Recombinant Human Growth Hormone in Children with Chronic Renal Failure”,Miner Electrolyte Metab., 1992, pp. 320-324, vol. 18.
Moncada, “Biological Importance of Prostacyclin”,Br. J. Pharmac., 1982, pp. 3-31, vol. 76.
Murphy, “Insulin-like growth factor-binding proteins: functional diversity or redundancy?”,Journal of Molecular Endocrinology, 1998, pp. 97-107, vol. 21.
Murphy et al., “Identification and Characterization of Genes Differentially Expressed in Meningiomas”,Cell Growth and Differentiation, 1993, pp. 715-722, vol. 4(9).
Ono et al., “Effect of high glucose concentrations on prostacyclin-stimulating factor mRNA expression in cultured aortic smooth muscle cells”,Diabetologica, 1998, pp. 134-140, vol. 41.
Ono et al., “Reduced Expression of a Novel Peptide, Prostacyclin-Stimulating Factor, in the Kidneys of Streptozotocin-Induced Diabetic Rats”,J. Diab. Comp., pp. 252-258, vol. 12, 1998.
Pereira et al., “Cortisol Enhances the Expression of mac25/Insulin-Like Growth Factor-Binding Protein-Related Protein-1 in Cultured Osteoblasts”,Endocrinology, 1999, pp. 228-232, vol. 140(1).
Pereira et al.., “Parathyroid Hormone Increases mac25/Insulin-Like Growth Factor-Binding Protein-Related Related Protein-1 Expression in Cultured Osteoblasts”Endocrinology, 1999, pp. 1998-2003, vol. 140(5).
Perks et al., “Insulin-Like Growth Factor Binding Proteins (IGFBPs) in Breast Cancer”Journal of Mammary Gland Biology and Neoplasia, 2000, pp. 75-84, vol. 5(1).
Rajaram et al., “Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions”,Endocrine Reviews, 1997, pp. 801-831, vol. 18(6).
Remuzzi et al., “Hæmolytic-Uræmic Syndrome: Deficiency of Plasma Factor(s) Regulating Prostacyclin Activity?”,The Lancet, pp. 871-872, 1978.
Rutanen et al., “Insulin-Like Growth Factors and Their Binding Proteins in Benign and Malignant Uterine Diseases”,The British Library, 1993, pp. 74-77, vol. 3.
Sekiguchi et al., “Immunohistochemical Study of Prostacyclin-Stimulating Factor (PSF) in the Diabetic and Atherosclerotic Human Coronary Artery”,Diabetes, 1997, pp. 1627-1632, vol. 46.
Schneider et al., “Transgenic mouse models for studyi
Furuya Akiko
Kobayashi Yuki
Nakamura Yusuke
Ota Toshio
Satoh Mitsuo
Kyowa Hakko Kirin Co., Ltd.
Saoud Christine J
Townsend and Townsend / and Crew LLP
LandOfFree
Antibodies to insulin-like growth factor binding protein and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to insulin-like growth factor binding protein and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to insulin-like growth factor binding protein and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4152788